    <SEC-DOCUMENT>0001140361-25-011855-index.html : 20250402
    <SEC-HEADER>0001140361-25-011855.hdr.sgml : 20250402
    <ACCEPTANCE-DATETIME>20250402160657
    ACCESSION NUMBER:		0001140361-25-011855
    CONFORMED SUBMISSION TYPE:	DEFA14A
    PUBLIC DOCUMENT COUNT:		3
    FILED AS OF DATE:		20250402
    DATE AS OF CHANGE:		20250402

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			Bausch Health Companies Inc.
    		CENTRAL INDEX KEY:			0000885590
    		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
    		ORGANIZATION NAME:           	03 Life Sciences
    		EIN:				000000000
    		STATE OF INCORPORATION:			NJ
    		FISCAL YEAR END:			1231

    	FILING VALUES:
    		FORM TYPE:		DEFA14A
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	001-14956
    		FILM NUMBER:		25804414

    	BUSINESS ADDRESS:
    		STREET 1:		2150 ST. ELZEAR BLVD. WEST
    		STREET 2:		LAVAL
    		CITY:			QUEBEC
    		STATE:			A8
    		ZIP:			H7L 4A8
    		BUSINESS PHONE:		514-744-6792

    	MAIL ADDRESS:
    		STREET 1:		2150 ST. ELZEAR BLVD. WEST
    		STREET 2:		LAVAL
    		CITY:			QUEBEC
    		STATE:			A8
    		ZIP:			H7L 4A8

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	Valeant Pharmaceuticals International, Inc.
    		DATE OF NAME CHANGE:	20100928

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	BIOVAIL Corp
    		DATE OF NAME CHANGE:	20100416

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	BIOVAIL CORP INTERNATIONAL
    		DATE OF NAME CHANGE:	19960522
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>DEFA14A
    <SEQUENCE>1
    <FILENAME>ny20039462x2_defa14a.htm
    <DESCRIPTION>DEFA14A
    <TEXT>
    Document 1 - file: ny20039462x2_defa14a.htm

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>2
    <FILENAME>ny20039462x2_nc01.jpg
    <TEXT>
    Document 2 - file: ny20039462x2_nc01.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>3
    <FILENAME>ny20039462x2_nc02.jpg
    <TEXT>
    Document 3 - file: ny20039462x2_nc02.jpg

    </DOCUMENT>
    </SEC-DOCUMENT>